Drug pricing decisions are now more critical than ever due to the expanding generics market, expiring patents and reduced new drug discoveries.
2008 ◽
Vol 544
(1)
◽
pp. 11-11
2012 ◽
Vol 668
(1)
◽
pp. 11-11
◽
2015 ◽
Vol 15
(6)
◽
pp. 1007-1014
◽